Logo
    Search

    Podcast Summary

    • Challenging the Accuracy of the Average Body TemperatureProfessor Macoviak discovered that the long-held belief of an average body temperature of 98.6 degrees Fahrenheit may not be accurate, as the original research was based on an atypical thermometer and less rigorous methods.

      The long-held belief that the average human body temperature is 98.6 degrees Fahrenheit (37 degrees centigrade) may not be entirely accurate. This belief, established by physician Carl Wunderlich in the mid-1800s, has been challenged by professor of medicine and medical historian Philip Macoviak. Macoviak, who specializes in clinical thermometry, discovered that Wunderlich's original thermometer was not typical and registered almost two degrees higher than current thermometers. Additionally, Macoviak found that Wunderlich's research methods were not as rigorous as modern standards, leading him to question the accuracy of the 98.6 degree average. Through his own study using modern thermometers, Macoviak found that human body temperatures vary more than previously thought, with an average closer to 97.9 degrees Fahrenheit (36.6 degrees centigrade).

    • Challenging the Norm: Body Temperature and Medicine's HistoryOnly 8% of body temperature readings are 98.6 degrees, the actual normal temperature is 98.2 degrees, and medical history includes numerous mistakes like lobotomies, mercury compounds, and the Tuskegee case.

      Our understanding of normal body temperature and the practices in medicine throughout history have not always been accurate. In the case of body temperature, only 8% of readings were found to be 98.6 degrees, challenging the notion of this temperature as the norm. Macoviak discovered the actual normal temperature to be 98.2 degrees. Temperature can vary greatly from person to person and throughout the day, and an elevated temperature doesn't always indicate illness. The history of medicine includes numerous mistakes, such as the use of lobotomies, overuse of mercury compounds, and the Tuskegee case, to name a few. As a medical historian, it's clear that future generations will question our current medical practices and the importance of maintaining a healthy skepticism towards them. In this three-part series of Freakonomics Radio, they will discuss medicine's greatest hits, failures, and the current state and future of medicine.

    • A brief history of ineffective and harmful medical practicesRecognizing the importance of questioning and challenging medical practices leads to advancements in healthcare.

      Throughout the history of medicine, particularly in the Western world, there have been numerous practices and treatments that were once considered legitimate but have since been proven to be ineffective or even harmful. These practices ranged from drilling holes in skulls to using toxic substances like mercury. However, instead of viewing this history with shame, it's important to recognize that the pursuit of health and wellness is complex and that progress often comes through trial and error. The ability to question and challenge existing practices has led to significant advancements in medicine over the past few decades. As doctors and healthcare professionals, it's crucial to remain open-minded and committed to continuous learning and improvement.

    • Exploring the mysteries of the human bodySignificant progress has been made in understanding the human body, but much remains unknown from the gross anatomy to the genetic level. Notable medical advancements continue to transform disease treatment.

      While we have made significant strides in understanding the human body from a medical perspective, there is still a vast amount that remains unknown. Historian Jeremy Green uses the concept of "known knowns" and "unknown unknowns" to illustrate this point. From the gross anatomy of the body to the microscopic level of cells and proteins, and even further down to the genetic level, our ability to explore and understand the human body continues to expand. Notable medical advancements, such as the discovery of insulin and the development of statins, have transformed the way we treat and manage various diseases. However, as historian Evelyn Hammons notes, every historian of science and medicine would have a different set of "greatest hits." Despite the progress, there is still a long way to go in fully understanding the complexities of the human body and its functions.

    • From anecdotes to evidence-based practicesThe integration of scientific methods into healthcare led to more effective and rational treatments, thanks to advancements in public health, new therapeutics, and controlled experiments.

      The advancements in healthcare and increased life expectancy over the past century and a half are the result of a combination of factors, including public health improvements, new therapeutics and medicines, and the use of controlled experiments. While breakthrough medicines have played a significant role, improvements in housing, sanitation, diet, and tackling urban problems were instrumental in reducing mortality from infectious diseases before the advent of antibiotics. The use of controlled clinical trials marked a turning point in medicine, shifting it from relying on anecdotes and charismatic leaders to evidence-based practices. However, even with the emphasis on evidence, it's important to note that practices can sometimes be reversed, as new research and understanding emerges. Overall, the integration of scientific methods into healthcare has been a game-changer, leading to more effective and rational treatments.

    • From eminence-based to evidence-based medicineThe Cochrane Collaboration, a global network, produces systematic reviews summarizing the best available research evidence, ensuring medical decisions are informed by reliable evidence accessible to all medical fields.

      The evolution of medicine from an eminence-based practice to an evidence-based one has been a significant shift. This transformation, driven by the increase in randomized controlled trials and advancements in computer technology, has led to the production of systematic reviews summarizing the best available research evidence. The Cochrane Collaboration, a global network that produces these reviews, has been a pioneer in this field, being the first to regularly update them, implement post-publication peer review, and have a strong conflict of interest policy. Unlike the past where doctors relied on their experience, opinions, or industry funding for information, the Cochrane Collaboration provides reliable evidence accessible to all medical fields. Sir Ian Chalmers, a co-founder, observed vast differences in medical practices in the past and recognized the need for a standardized evidence base. Today, the Cochrane Collaboration continues to play a crucial role in ensuring that medical decisions are informed by the best available evidence.

    • Discovering the need for evidence-based medicine through tragic consequencesDr. Iain Chalmers' experience at a refugee camp led to the establishment of the Cochrane Collaboration, emphasizing the importance of evidence-based medicine and randomized trials in providing the best care for patients.

      The importance of evidence-based medicine was brought to light when Dr. Iain Chalmers discovered the fatal consequences of outdated medical knowledge during his work at a refugee camp in Gaza. He found that children with measles were dying from bacterial infections due to the lack of preventative antibiotics, despite medical school teachings against it. Frustrated and saddened, Chalmers embarked on a mission to systematically review and compile medical research to provide the best evidence for medical questions. The Cochrane Collaboration was born, and despite initial resistance from the medical community, it became the new standard for evidence-based medicine in the late 1980s and early 2000s. The use of randomized trials, which provide clear cause-and-effect evidence, became more common and mandatory. The story of Dr. Chalmers highlights the importance of continually challenging outdated medical knowledge and relying on solid evidence to improve patient care.

    • Medical reversals: Contradicting long-held medical practices with new evidenceRigorous scientific evidence is crucial in medicine to challenge and update long-held beliefs and practices, as shown by medical reversals.

      The practice of medicine involves making diagnoses and prescribing treatments based on the best available evidence at the time. However, the feedback loop in medicine is often sloppy, making it difficult to determine if a treatment was effective or not. This was highlighted in the late 1980s with the Cardiac Arrhythmia Suppression Trial (CAST), which showed that a commonly prescribed antiarrhythmic drug did not improve survival as previously believed but actually worsened it. Such contradictions to long-held medical practices are called medical reversals, and they underscore the importance of rigorous scientific evidence in guiding medical treatment. For instance, the recommendation for post-menopausal women to take estrogen supplements based on observational data was contradicted by a well-designed randomized controlled trial in 2002, which found that they increased the risk of heart attacks and strokes rather than decreasing them. Vinay Prasad, an expert on medical reversals, became interested in this phenomenon while still a student, observing that contradicted practices still persisted in hospitals despite newer, better evidence. In summary, the importance of rigorous scientific evidence in medicine cannot be overstated, as even widely held beliefs can be contradicted by well-designed studies.

    • Issue of Indication Drift in Medical ProceduresDespite studies showing ineffectiveness, doctors continue to perform unnecessary procedures like stenting for stable angina due to financial incentives, leading to loss of faith in medical system if patients are not informed.

      Many medical procedures and treatments, including stenting for stable angina, have undergone "indication drift," where they are used for conditions for which they may not be effective. Studies have shown that stenting for stable angina does not improve survival or decrease heart attacks, yet the rate of inappropriate stenting remains high. This issue raises questions about doctors' incentives and financial considerations. Other treatments, such as certain knee surgeries and cement injections for broken vertebral bones, have also been found to be placebo effects. While new studies often conclude that newer is better, studies testing existing treatments often find contradictions or reversals. These reversals could lead to a loss of faith in the medical system if patients are not informed of the latest research. It is crucial for medical professionals to stay informed of the latest research and communicate effectively with their patients about the effectiveness and necessity of various treatments.

    • Prioritizing evidence-based medicine and ethical practices to minimize medical reversalsMedical field should prioritize evidence-based medicine, effective regulation, and ethical practices to minimize harmful medical reversals. Regulation should ensure only safe and effective treatments are approved, especially for rare conditions. Physicians should communicate uncertainty clearly to patients.

      The medical field must prioritize evidence-based medicine and education, effective regulation, and ethical practices to minimize the occurrence of harmful medical reversals. The current system, where basic science is taught before evidence-based medicine, needs to be flipped. Regulation should be adjusted to ensure that only safe and effective treatments are approved, especially for conditions with many options and low incidence. Lastly, physicians must communicate uncertainty clearly to patients when offering uncertain treatments. The consequences of medical reversals include causing harm, lag time harm, and loss of trust in the medical system. These issues have been highlighted in recent years with shifting recommendations for mammography and prostate cancer screening. It's crucial to address these challenges to maintain trust and confidence in the medical profession.

    • Barriers to an evidence-based healthcare industryHigh costs and entrenched interests hinder the healthcare industry's progress towards becoming more evidence-based, with the pharmaceutical industry's excessive pricing and exclusion of certain populations in clinical trials being major contributors

      The healthcare industry, specifically in the United States, faces significant barriers in becoming more evidence-based due to entrenched interests and high costs. The pharmaceutical industry, for instance, has been criticized for pricing drugs excessively, with the average cancer drug costing over $100,000 per year. Additionally, clinical trials have historically excluded certain populations, such as women and vulnerable groups, leading to questions about the representativeness of the data. These issues contribute to the healthcare sector's resistance to change and hinder the progress towards a more scientific and evidence-based approach.

    Recent Episodes from Freakonomics Radio

    593. You Can Make a Killing, but Not a Living

    593. You Can Make a Killing, but Not a Living

    Broadway operates on a winner-take-most business model. A runaway hit like Stereophonic — which just won five Tony Awards — will create a few big winners. But even the stars of the show will have to go elsewhere to make real money. (Part two of a two-part series.)

     

     

     

    Freakonomics Radio
    en-usJune 20, 2024

    EXTRA: The Fascinatingly Mundane Secrets of the World’s Most Exclusive Nightclub

    EXTRA: The Fascinatingly Mundane Secrets of the World’s Most Exclusive Nightclub

    The Berlin dance mecca Berghain is known for its eight-hour line and inscrutable door policy. PJ Vogt, host of the podcast Search Engine, joins us to crack the code. It has to do with Cold War rivalries, German tax law, and one very talented bouncer.

     

    • SOURCES:
      • Lutz Leichsenring, executive board member of Clubcommission Berlin and co-founder of VibeLab.
      • PJ Vogt, reporter, writer, and host of the podcast Search Engine.

     

     

    Freakonomics Radio
    en-usJune 17, 2024

    592. How to Make the Coolest Show on Broadway

    592. How to Make the Coolest Show on Broadway

    Hit by Covid, runaway costs, and a zillion streams of competition, serious theater is in serious trouble. A new hit play called Stereophonic — the most Tony-nominated play in history — has something to say about that. We speak with the people who make it happen every night. (Part one of a two-part series.)

     

     

    Freakonomics Radio
    en-usJune 13, 2024

    591. Signs of Progress, One Year at a Time

    591. Signs of Progress, One Year at a Time

    Every December, a British man named Tom Whitwell publishes a list of 52 things he’s learned that year. These fascinating facts reveal the spectrum of human behavior, from fraud and hypocrisy to Whitwell’s steadfast belief in progress. Should we also believe?

     

     

    Freakonomics Radio
    en-usJune 06, 2024

    EXTRA: The Opioid Tragedy — How We Got Here

    EXTRA: The Opioid Tragedy — How We Got Here

    An update of our 2020 series, in which we spoke with physicians, researchers, and addicts about the root causes of the crisis — and the tension between abstinence and harm reduction.

     

    • SOURCES:
      • Gail D’Onofrio, professor and chair of emergency medicine at the Yale School of Medicine and chief of emergency services at Yale-New Haven Health.
      • Keith Humphreys, professor of psychiatry and behavioral sciences at Stanford University.
      • Stephen Loyd, chief medical officer of Cedar Recovery and chair of the Tennessee Opioid Abatement Council.
      • Nicole O’Donnell, certified recovery specialist at the University of Pennsylvania's Center for Addiction Medicine and Policy.
      • Jeanmarie Perrone, professor of emergency medicine at the University of Pennsylvania.
      • Eileen Richardson, restaurant manager.

     

     

    Freakonomics Radio
    en-usJune 03, 2024

    590. Can $55 Billion End the Opioid Epidemic?

    590. Can $55 Billion End the Opioid Epidemic?

    Thanks to legal settlements with drug makers and distributors, states have plenty of money to boost prevention and treatment. Will it work? (Part two of a two-part series.)

     

    • SOURCES:
      • Keith Humphreys, professor of psychiatry and behavioral sciences at Stanford University.
      • Stephen Loyd, chief medical officer of Cedar Recovery and chair of the Tennessee Opioid Abatement Council.
      • Christine Minhee, founder of OpioidSettlementTracker.com.

     

     

    Freakonomics Radio
    en-usMay 30, 2024

    589. Why Has the Opioid Crisis Lasted So Long?

    589. Why Has the Opioid Crisis Lasted So Long?

    Most epidemics flare up, do their damage, and fade away. This one has been raging for almost 30 years. To find out why, it’s time to ask some uncomfortable questions. (Part one of a two-part series.)

     

    • SOURCES:
      • David Cutler, professor of economics at Harvard University.
      • Travis Donahoe, professor of health policy and management at the University of Pittsburgh.
      • Keith Humphreys, professor of psychiatry and behavioral sciences at Stanford University.
      • Stephen Loyd, chief medical officer of Cedar Recovery and chair of the Tennessee Opioid Abatement Council.

     

     

    Freakonomics Radio
    en-usMay 23, 2024

    Extra: Car Colors & Storage Units

    Extra: Car Colors & Storage Units

    Presenting two stories from The Economics of Everyday Things: Why does it seem like every car is black, white, or gray these days? And: How self-storage took over America.

     

    • SOURCES:
      • Tom Crockett, classic car enthusiast.
      • Zachary Dickens, executive vice president and chief investment officer of Extra Space Storage.
      • Mark Gutjahr, global head of design at BASF.
      • Kara Kolodziej, self-storage unit tenant.
      • Anne Mari DeCoster, self-storage consultant.
      • Nikkie Riedel, carline planning manager at Subaru of America.

     

     

    Freakonomics Radio
    en-usMay 20, 2024

    588. Confessions of a Black Conservative

    588. Confessions of a Black Conservative

    The economist and social critic Glenn Loury has led a remarkably turbulent life, both professionally and personally. In a new memoir, he has chosen to reveal just about everything. Why?

     

    • SOURCE:
      • Glenn Loury, professor of economics at Brown University and host of The Glenn Show.

     

     

    Freakonomics Radio
    en-usMay 16, 2024

    587. Should Companies Be Owned by Their Workers?

    587. Should Companies Be Owned by Their Workers?

    The employee ownership movement is growing, and one of its biggest champions is also a private equity heavyweight. Is this meaningful change, or just window dressing?

     

    • SOURCES:
      • Marjorie Kelly, distinguished senior fellow at The Democracy Collaborative.
      • Corey Rosen, founder and senior staff member of the National Center for Employee Ownership.
      • Pete Stavros, co-head of Global Private Equity at KKR.

     

     

    Related Episodes

    Salamander search party

    Salamander search party
    One of the world’s most biodiverse aquifers is full of strange, blind creatures that have evolved in isolation for millions of years. But one is missing. This episode was reported by Benji Jones and Mandy Nguyen, who produced the episode. Editing from Meradith Hoddinott, Katherine Wells, Brian Resnick, and Noam Hassenfeld, who scored the episode. Mixing and sound design from Cristian Ayala. Fact-checking from Richard Sima. For more, go to http://vox.com/unexplainable It’s a great place to view show transcripts and read more about the topics on our show. Also, email us! unexplainable@vox.com We read every email. Support Unexplainable by making a financial contribution to Vox! bit.ly/givepodcasts Learn more about your ad choices. Visit podcastchoices.com/adchoices

    #1958 - Andrew Huberman

    #1958 - Andrew Huberman

    Andrew Huberman, PhD, is a neuroscientist and tenured professor at Stanford University’s School of Medicine. Andrew is also the host of the Huberman Lab podcast, which aims to help viewers and listeners improve their health with science and science-based tools. New episodes air every Monday on YouTube and all podcast platforms.

    www.hubermanlab.com

    The Long Legacy Of The Arecibo Telescope

    The Long Legacy Of The Arecibo Telescope
    The National Science Foundation recently announced it plans to decommission the Arecibo Telescope in Puerto Rico. The world-renowned telescope has suffered substantial damage this year. Today, we revisit our conversation with planetary scientist Edgard Rivera-Valentín about the unique role Arecibo has played in both scientific research and popular culture. (Encore episode.)

    Email the show at shortwave@npr.org.

    Learn more about sponsor message choices: podcastchoices.com/adchoices

    NPR Privacy Policy